TD Cowen Maintains Buy on GRAIL, Raises Price Target to $180
10/13/2026
Impact: 85
Healthcare
TD Cowen analyst Dan Brennan has maintained a Buy rating on GRAIL (NASDAQ: GRAL) and increased the price target from $88 to $180.
AI summary, not financial advice
Share: